EN
HI

NURECA Share price

NURECA

HealthcareSmall

226.38

4.63 (-2.00%)
NSE
BSE
Last updated on 2 May, 2025 | 15:15 IST
BUYSELL
Today's High

226.38

Today's Low

230.01

52 Week Low

447.50

52 Week High

447.50

The current prices are delayed, login to your account for live prices

Nureca Chart

NURECA Share Key Metrics

Volume
1804.00
Market Cap
231.01 CR
LTQ@LTP
600@226.38
ATP
226.76
Var Margin
10000
Circuit Range
226.38-235.63
Delivery %
0
Value
4.09 L
ASM/GSM
No
Market Lot
1

NURECA Futures & Options

Data Not Found

NURECA Corporate Actions

DateAgenda
2025-05-05Audited Results
2025-01-24Quarterly Results
DateEvent TypeAgenda
2025-05-05Board MeetingAudited Results
2025-01-24Board MeetingQuarterly Results

NURECA News

Nureca signs distribution agreement with Zepto

Nov 16 2024 14:01:52

Nureca signs distribution agreement with Zepto

Nov 16 2024 13:56:51
Read More

About NURECA

NSE : 2353  
BSE : 543264  
ISIN : INE0DSF01015  

The Company was incorporated as ‘Nureca Private Limited’ as a private limited company under the Companies Act 2013 on November 2 2016 and a certificate of incorporation was issued by Registrar of Companies Central Registration Centre at Delhi. The registered office of the Company was changed from Delhi to Mumbai Maharashtra pursuant to certificate of registration of regional director order dated January 8 2019 for change of state issued by the RoC with effect from February 8 2019. Upon to conversion into a public limited company pursuant to a special resolution passed in the extra ordinary general meeting of the shareholders of the Company held on June 19 2020 the name of the Company was changed to the present name ‘Nureca Limited’ and a fresh certificate of incorporation was issued by the RoC on July 8 2020.The Company became a wholly owned Subsidiary of Nectar Biopharma Private Limited on August 16 2018. Pursuant to the Scheme of Arrangement approved by the NCLT Special Bench Mumbai vide its order dated April 29 2020 the Specified Undertaking (as defined in the Scheme of Arrangement) was demerged from Nectar Biopharma Private Limited and vested into the Company. Consequently 1 equity share of face value Rs.10 each of the Company was issued to each shareholders of Nectar Biopharma Private Limited for every 1 equity shares of face value Rs.10 each held by them in Nectar Biopharma Private Limited as on the record date i.e. June 9 2020.Major Events and Milestones :2016- Online launch of Dr. Trust Brand.2017- Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.- Started three flex centres in Punjab Karnataka and Uttar Pradesh.2018- The Company became the wholly owned subsidiary of Nectar Biopharma Private Limited.- Added three flex centres in Chandigarh Telangana and Maharashtra.- Secured warehouse drug license.2020- Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the Company pursuant to the Scheme of Arrangement.Key awards recognitions and accreditations received by the Company :2020- The Company received ISO 9001:2015 Certificate of Registration from Intertek Certification Limited for Management System which is applicable to sales services and warehousing of medical devices consumer electronics pharmaceutical and personal care products.- Appreciation Letter from Pharmaceuticals Export Promoter Council of India stating the Company as a very dynamic and evolving medical devices company and has created a credible and leading brand “Dr. Trust” which is now a household name in India.

NURECA Management

NamePosition
Mr. Saurabh Goyal Chairman & Managing Director
Mr. Aryan Goyal WholeTime Director & CEO
Mr. Rajinder Sharma Whole Time Director
Ms. Charu Singh Independent Director
Ms. Ruchita Agarwal Independent Director
Read More

NURECA FAQs

The Buying Price of NURECA share is 0 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy NURECA share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of NURECA shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio NURECA shares is 1.2. Useful to assess the stock's value relative to its book value.

To assess NURECA’s valuation compare Sector P/E, P/B which are 20 & 2.73 with sector averages, along with growth rates and financial metrics.

The Market Cap of NURECA is 231.01 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of NURECA share price is 447.50 & 203.62. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.